The project will provide innovative understanding about the pivotal role of an oncogenic ncRNA cluster in partial EMT and hopefully identify biomarkers and novel targeting treatment for HNSCC, reducing patient suffering and saving health care cost.
|Effective start/end date||8/1/22 → 7/31/23|
- Head and neck squamous cell carcinoma (HNSCC)
- epithelial to mesenchymal transition (EMT)
- partial EMT (pEMT)
- ncRNA cluster
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.